Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
Launched by MINIA UNIVERSITY ·
Trial Information
Current as of September 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help patients who are having surgery on their pancreas, specifically those with certain types of cancers like pancreatic, bile duct, or duodenal cancer. The researchers want to see if using a special medical glue called Glubran® 2 during surgery can reduce the chances of a common complication called a pancreatic fistula. A pancreatic fistula happens when fluid leaks from the pancreas after surgery, which can cause problems and delay healing. The trial will compare patients who receive the glue during their surgery to those who have the standard procedure without the glue, focusing on how often this leakage happens within 30 days after surgery.
People who might be eligible for this study are adults having a specific type of pancreas surgery called pancreaticoduodenectomy, particularly those with a “soft” pancreas, which can increase the risk of leaks after surgery. The trial plans to enroll about 194 patients and is currently not yet recruiting. If you join, you will be randomly assigned to have surgery either with or without the special glue, and doctors will monitor you closely for any complications and how long you stay in the hospital. This study is being done at a single medical center and aims to improve recovery and safety for patients undergoing this complex surgery.
Gender
ALL
Eligibility criteria
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Saleh K Saleh, MD
Principal Investigator
Minia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported